Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Mayuko Kondo"'
Autor:
David Rabbolini, Hai Po Helena Liang, Marie-Christine Morel-Kopp, David Connor, Shane Whittaker, Scott Dunkley, Dea Donikian, Mayuko Kondo, Walter Chen, William S Stevenson, Heather Campbell, Joanne Joseph, Christopher Ward, Timothy Brighton, Vivien M. Chen
Publikováno v:
Platelets, Vol 33, Iss 3, Pp 432-442 (2022)
Variants of the Diaphanous-Related Formin 1 (DIAPH-1) gene have recently been reported causing inherited macrothrombocytopenia. The essential/”diagnostic” characteristics associated with the disorder are emerging; however, robust and complete cri
Externí odkaz:
https://doaj.org/article/d311c6db4659402dae1b3b6d8838bf61
Autor:
Junya Arai, Jun Kato, Nobuo Toda, Ken Kurokawa, Chikako Shibata, Shigeyuki Kurosaki, Kazuyoshi Funato, Mayuko Kondo, Kaoru Takagi, Kentaro Kojima, Takamasa Ohki, Michiharu Seki, Kazumi Tagawa
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Impairment of activities of daily living (ADL) due to hemorrhagic gastroduodenal ulcers (HGU) has rarely been evaluated. We analyzed the risk factors of poor prognosis, including mortality and impairment of ADL, in patients with H
Externí odkaz:
https://doaj.org/article/1bb52487853e4e59831f7fd9529441c1
Autor:
Takamasa Ohki, Koki Sato, Mayuko Kondo, Eriko Goto, Takahisa Sato, Yuji Kondo, Masatoshi Akamatsu, Shinpei Sato, Hideo Yoshida, Yukihiro Koike, Shuntaro Obi
Publikováno v:
Liver Research, Vol 4, Iss 4, Pp 199-205 (2020)
Background and aims: Lenvatinib (LEN) is a newly developed tyrosine kinase inhibitor, and is approved as a first-line treatment for advanced hepatocellular carcinoma (HCC) in Japan. This retrospective multi-center study investigated the effect of the
Externí odkaz:
https://doaj.org/article/49123965d8f046a6b238f35da0fd3112
Publikováno v:
Liver Research, Vol 4, Iss 4, Pp 206-211 (2020)
Background: Although radiofrequency ablation (RFA) is a minimally invasive treatment for early-stage hepatocellular carcinoma (HCC), it remains unclear whether RFA achieves favorable outcomes in patients aged ≥80 years. This study aimed to determin
Externí odkaz:
https://doaj.org/article/e2651384fca04552847544a0d2e3687e
Autor:
Satoshi Kawamura, Yuki Karasawa, Nobuo Toda, Yousuke Nakai, Chikako Shibata, Ken Kurokawa, Junya Arai, Kazuyoshi Funato, Shigeyuki Kurosaki, Shuya Maeshima, Mayuko Kondo, Kentaro Kojima, Takamasa Ohki, Michiharu Seki, Kazuhiko Koike, Kazumi Tagawa
Publikováno v:
Gut and Liver, Vol 14, Iss 6, Pp 842-849 (2020)
Background/Aims: Empiric antibiotics are given in combination with biliary drainage for acute cholangitis but sometimes turn out to be insensitive to microorganisms in blood and bile. Clinical outcomes were compared according to sensitivity to microo
Externí odkaz:
https://doaj.org/article/ee46b4aec10543c3a1fe94c0e89e1909
Autor:
Ken Kurokawa, Takamasa Ohki, Jun Kato, Yukiyo Fukumura, Makoto Imai, Chikako Shibata, Junya Arai, Mayuko Kondo, Kaoru Takagi, Kentaro Kojima, Michiharu Seki, Masaya Mori, Nobuo Toda, Kazumi Tagawa
Publikováno v:
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-6 (2020)
Abstract Background Combination therapy of interferon and ribavirin has traditionally been used to eradicate hepatitis C virus. The sustained virologic response achieved with interferon-related therapy is persistent, and late relapses after achieving
Externí odkaz:
https://doaj.org/article/02fc2fcf54ae4999bef82c837bc6d003
Autor:
Takamasa Ohki, Koki Sato, Mayuko Kondo, Eriko Goto, Takahisa Sato, Yuji Kondo, Masatoshi Akamatsu, Shinpei Sato, Hideo Yoshida, Yukihiro Koike, Shuntaro Obi
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss 2, Pp 141-149 (2020)
Abstract Background and Objective Experience of the use of lenvatinib (LEN) in the clinical setting remains limited. We conducted this study to elucidate the factors associated with progression-free survival (PFS) in patients with advanced HCC treate
Externí odkaz:
https://doaj.org/article/a0fbba4ad7974a68962730adec11987e
Autor:
Chikako Shibata, Jun Kato, Nobuo Toda, Makoto Imai, Yukiyo Fukumura, Junya Arai, Ken Kurokawa, Mayuko Kondo, Kaoru Takagi, Kentaro Kojima, Takamasa Ohki, Michiharu Seki, Masanobu Yoshida, Akitake Suzuki, Kazumi Tagawa
Publikováno v:
Journal of Medical Case Reports, Vol 13, Iss 1, Pp 1-6 (2019)
Abstract Background While dermatomyositis is often associated with malignancy, several autoimmune diseases like myositis can be caused by immune checkpoint inhibitors. Differentially diagnosing malignancy-associated dermatomyositis or myositis caused
Externí odkaz:
https://doaj.org/article/5f2a282666df4ecda51bd852c56cdcfe
Autor:
Yoshinari Asaoka, Ryosuke Tateishi, Ryo Nakagomi, Mayuko Kondo, Naoto Fujiwara, Tatsuya Minami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Hayato Nakagawa, Yuji Kondo, Shuichiro Shiina, Haruhiko Yoshida, Kazuhiko Koike
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e111662 (2014)
BackgroundVascular invasion in patients with hepatocellular carcinoma (HCC) is representative of advanced disease with an extremely poor prognosis. The detailed course of its development has not been fully elucidated.MethodsWe enrolled 1057 consecuti
Externí odkaz:
https://doaj.org/article/8a8779e65ec84095a67797a1edc9ca1d
Autor:
Masaya Sato, Mayuko Kondo, Ryosuke Tateishi, Naoto Fujiwara, Naoya Kato, Haruhiko Yoshida, Masataka Taguri, Kazuhiko Koike
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91822 (2014)
BACKGROUND & AIMS:IL28B polymorphisms were shown to be strongly associated with the response to interferon therapy in chronic hepatitis C (CHC) and spontaneous viral clearance. However, little is known about how these polymorphisms affect the natural
Externí odkaz:
https://doaj.org/article/e50370a30529419faf551f730e2e5013